Hoi Fong Chan, M.D., BCMAS, is currently the Executive Medical Director for Taiwan and Hong Kong at Eli Lilly and Company. They serve as a guest reviewer for the Journal of Neurology, Neurosurgery, and Psychiatry and work as an adjunct attending neurologist at En Chu Kong Hospital. Hoi Fong Chan is also pursuing a Doctor of Medicine degree and is a PhD student in neurobiology at National Taiwan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices